Contineum Therapeutics, Inc. (CTNM)
11.55
-0.03
(-0.26%)
USD |
NASDAQ |
Dec 16, 16:00
11.77
+0.22
(+1.90%)
After-Hours: 20:00
Contineum Therapeutics EPS Diluted (Quarterly): -0.455 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | -0.736 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| CG Oncology, Inc. | -0.5709 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.79M |
| Total Expenses (Quarterly) | 12.79M |
| Enterprise Value | 121.90M |
| Earnings Yield | -19.53% |
| Normalized Earnings Yield | -19.53 |